Towards an improved investment approach for an effective response to HIV Dr Bernhard Schwartländer UNAIDS.

Slides:



Advertisements
Similar presentations
Supporting community action on AIDS in developing countries Supporting community action on AIDS in India Children Affected By AIDS in Low and Concentrated.
Advertisements

HIV/AIDS in Ethiopia Daniel Yilma Jimma Univeristy, Ethiopia.
Asia and Pacific Overview of the HIV Epidemic and Response JVR Prasada Rao Regional Support Team Asia & Pacific Bangkok ICAAP, Kobe, July 2005.
Taking Another Look at Condoms Patrick Friel Reproductive Health HIV/AIDS Consultancy 27 April 2006.
Adapting National HIV Strategy to a Socially and Geographically Concentrated Epidemic: The Case of Papua New Guinea Dr. Moale Kariko PNG.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Key Policy Issues: 2013 Pan-African Parliament / UNAIDS Dialogue Pride Chigwedere, MD, PhD Senior Advisor, UNAIDS Liaison Office to the AU.
Dr Susan Zimba –Tembo Professional Officer – WHO 1 st March 2013, Crest Golf Hotel.
Supporting community action on AIDS in developing countries MDG’s and the Law: Creating an Enabling Legislative Environment Anton Kerr Head of Policy –
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
People receiving antiretroviral therapy, 2005 to June 2014, all countries.
UNAIDS, Regional Support Team, Eastern and Southern Africa
David Wilson Cost-effectiveness of HIV financing.
9.7 million people on ART by end of
UNAIDS Sharing Experiences from SA Workplace Wellness Dialogues Dr Miriam Chipimo Senior Policy & Programme Adviser SA BCOHA &ILO Pre-Conference Workshop.
DPG-AIDS Welcome Michelle Roland, Lead On behalf of DPG-AIDS.
Future HIV Financing Direction: Reality Check Brian Rettmann, PEPFAR Country Coordinator.
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
Washington D.C., USA, July 2012www.aids2012.org Estimating the Costs and Impacts of HIV/AIDS Programs for Botswana Examples of the ART Program and.
HIV resource needs case studies: Belarus and Armenia
AIDS IN ASIA – PRIORITIZING AND SUSTAINING THE RESPONSE IN THE ECONOMIC CRISIS Hanoi September 2009 ADB Consultant Ross McLeod.
IF : 1 FUNDING SLOWDOWN. IF : 2 BUILDS ON PAST, BUT DOES BETTER WE HAVE DONE A LOT… Unprecedented scale up of HIV prevention, treatment, care and support.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Sustainable Financing for the AIDS, TB and Malaria Responses Pride Chigwedere, MD, PhD Senior Advisor, UNAIDS Liaison Office to the AU.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
There is no single epidemic in the Middle East and North Africa – learning from facts to shape the AIDS response UNAIDS Secretariat, the World Bank and.
Resource Needs Model Rachel Sanders October 28 th, 2010.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
Historical Mapping of HIV Programmes 1985 – 2012 in Malawi Presented at the 20 TH INTERNATIONAL AIDS CONFERENCE, MELBOURNE, AUSTRALIA 24 th July 2014 By.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
ACHAP Economic and Social Impact Assessment. ACHAP Support Methods Epidemiological Impact Economic Impact Outline.
The National HIV Counselling and Testing Campaign and Treatment Expansion in South Africa: A return on investments in combination prevention XIX International.
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 1.
Efficiency, Effectiveness, and Financial Sustainability: The Importance of Country Ownership Dr Bernhard Schwartländer UNAIDS.
The Effects of Different ART Eligibility Strategies on HIV-Related Mortality and Incidence John Stover, Carel Pretorius, Lori Bollinger Futures Institute.
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
Managing adolescents and young people with HIV: Challenges and Solutions: Introduction Dr. Tajudeen Oyewale, MD, MPH, PhD. HIV Section, UNICEF New York.
Evidence-based strategic investment to sustain the HIV response Conference on Measuring and Achieving Universal Health Coverage (UHC) with Information.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
An Historic Opportunity to Prevent the Spread of HIV Timothy Hallett Imperial College London Members of The Applied HIV Epidemiology Research Group / HIV.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
The HIV Response Where are we now?
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Financing HIV, Hepatitis and STI Strategies:
27 years of responding to AIDS
HIV and SRH – the national picture in the Philippines
Needle and syringe exchange and working with injecting drug users
27 years of responding to AIDS
Tuberculosis/HIV co-treatment Conditional cash transfers
Global epidemiology of injecting drug use
وضعیت HIV/AIDS در جهان ومنطقه مرکز مدیریت بیماری ها - اداره كنترل ایدز و بیماری های آمیزشی
Pre-conference Meeting Report
27 years of responding to AIDS
Finding the right target population for PrEP The cost-effectiveness of PrEP provision to adolescents and young women in South Africa Gesine Meyer-Rath1,2,
Approaches to service delivery and the implications for public administration Dr. Vincent Bagambe (MoH-Global Fund, Uganda)
Dr Celestine Mugambi National AIDS Control Council, Kenya
Brief overview of HIV among MSM in the EU/EEA
Evaluating the cost-effectiveness of the test and treat program in Zimbabwe
Global Optimization of the Response to HIV
Showing throughout the event
The HIV Epidemic among People who Inject Drugs
AIDS-related deaths the lowest this century
Hidden Opportunities - What Will It Take to Reach in Eastern Europe?
Key Affected Populations
SETTING TARGETS TO DRIVE DECISIONS MAKING AND ACOUNTABILITY
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Presentation transcript:

Towards an improved investment approach for an effective response to HIV Dr Bernhard Schwartländer UNAIDS

We have done a lot … Unprecedented scale up of services Decline in rate of new HIV infections in many countries More than 6.5 M on ART But we can do better Scale up to date guided by “commodity approach” Unsystematic prioritisation and investment Resources spread thinly across many parallel interventions Focus on discrete interventions rather than overall results leading to a fragmented response

A shift in paradigm Strategic investment based on prioritisation and driven by latest evidence

What can we achieve? Universal Access by 2015

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% > <50 CD4 Count (cells/ml) Coverage ART coverage in 2015 by CD4 count 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% > <50 CD4 Count (cells/ml) Coverage 13.1 million (health) CD million (T4P)

Reaching people with services: Examples for 2015 Coverage Condoms (discordant couples)60% Condoms (high risk pop)50% Sex work60% MSM programmes60% IDU programmes60% Million HIV testing320 ART15

Return on investment: More than 12 million infections averted

9 Annual number of AIDS deaths: Life years gained 29.4 million

What will it cost? What are the returns?

11 Resources needed for the investment framework

Economic cost and returns 2011 to 2020 Cost/Returns Total additional investment (over 10 years) US$46.5 Billion Future treatment need averted US$40 Billion Life years gained US$1,060 per life year gained

Conclusions Through a focused and committed approach we can turn this epidemic around With an upfront investment over the coming 5 years, we will be able to turn cost around Time to overcome the false dichotomy between prevention and treatment In line with the commitments and targets included in the Declaration of the HLM AIDS The Lancet Vol 377 June 11, Available online at